Traders Purchase High Volume of Put Options on Evelo Biosciences (NASDAQ:EVLO)

Evelo Biosciences, Inc. (NASDAQ:EVLO) was the recipient of unusually large options trading activity on Wednesday. Traders bought 1,885 put options on the company. This is an increase of approximately 1,101% compared to the typical volume of 157 put options.

Evelo Biosciences Price Performance

Evelo Biosciences stock opened at $0.00 on Thursday. Evelo Biosciences has a 52 week low of $0.00 and a 52 week high of $0.00. The company has a market capitalization of $5,652.00, a P/E ratio of 0.00 and a beta of 0.61.

Evelo Biosciences Company Profile

Evelo Biosciences is a clinical-stage biotechnology company developing orally delivered immunomodulatory therapies that leverage the gut-body network. The company’s proprietary platform is designed to mimic signals normally generated by gut commensal bacteria to regulate immune function throughout the body. Evelo’s approach focuses on non-live, inactivated microbial derivatives, aiming to offer a new class of biologics that can be administered by mouth and engage mucosal immune pathways to treat a range of diseases.

The company’s pipeline spans inflammatory, autoimmune and oncology indications.